International Marijuana Business News

Though a ‘positive step,’ WHO recommendations on cannabis fall short for some

Published February 1, 2019 | By Alfredo Pascual

The World Health Organization (WHO) made great strides in its recommendations on how cannabis should be scheduled, but the global industry believes there’s more work to be done. Martin Jelsma, drugs and democracy program director, at the Netherlands-based Transnational Institute, emphasized to Marijuana Business Daily that there are “very positive elements in the WHO recommendations,” including: Recognition […]

Read More

MJBizDaily launches content for high-level cannabis investors

Published February 1, 2019

Investment in cannabis has grown at a meteoric pace – in size and in volume – over the past 12 months. To keep investors apprised of the rapid changes, Marijuana Business Daily has launched a subscription service – Investor Intelligence – focused on the critical analysis, insights and data necessary for success in the sector. “The demand for […]

Read More

Victoria’s aim to be Australian ‘cannabis capital’ challenged by patient access issues

Published January 31, 2019 | By Matt Lamers

An Australian state’s ambition to be the nation’s “medical cannabis capital” is unlikely to succeed unless market access for local patients substantially improves, experts note. Patient access to medical cannabis remains a serious concern despite marked improvements over the past year. “The crux of the problem is, we can’t produce medical cannabis products for our market […]

Read More

Big Pharma ‘missing link’ in Canada’s emerging marijuana industry

Published January 31, 2019 | By Matt Lamers

The entrance of multinational pharmaceutical companies into Canada’s cannabis sector will mark one of the next major themes in the industry, analysts told Marijuana Business Daily. Such eventual moves by Big Pharma will provide even more credibility to a sector that has already seen the entrance of alcohol and tobacco giants. “The missing link is […]

Read More

Canadian cannabis firm Green Growth enters Arizona with $12M Desert Rose purchase

Published January 31, 2019

Toronto-based Green Growth Brands is entering its third U.S medical marijuana market with the $12.35 million cash acquisition of ZLJT and Arizona Natural Pain Solutions, better known collectively as Desert Rose. Arizona had 186,000 registered MMJ patients as of December 2018. Desert Rose serves roughly 400 medical marijuana patients daily. Green Growth, which trades on the Canadian […]

Read More

Molson Coors CBD-beverage partner Hexo closes CA$57.6 million share offering

Published January 30, 2019

Hexo Corp., a licensed producer of cannabis based in Quebec, Canada, raised 57.6 million Canadian dollars ($43.7 million) Wednesday when it closed its offering of common shares. The company said in a news release it will use the proceeds for global expansion and research and development. The Quebec cultivator, which trades as Hexo on the Toronto Stock […]

Read More

What cannabis shortage? Canada has ‘sufficient supply,’ Ottawa says

Published January 30, 2019 | By Matt Lamers

Canada’s federal government says the country has more than enough legal cannabis to meet demand even as some provinces complain about shortages. “The data is clear: There remains sufficient supply to meet and exceed existing demand,” Bill Blair, Canada’s minister in charge of marijuana, said Wednesday via Twitter after receiving queries from Marijuana Business Daily. […]

Read More

In race to win Europe, Aurora Cannabis and other Canadian companies pursue EU-GMP

Published January 30, 2019 | By Matt Lamers

In an effort to add to their international credibility and gain leverage over competitors, more Canadian medical marijuana firms are aiming to achieve one of the highest levels of quality certification in the world. Only a handful of licensed cultivators in Canada qualify for the EU-Good Manufacturing Practices (EU-GMP) certification, giving them an advantage when […]

Read More